Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
PE fund Somerset invests in Gujarat-based bulk drug firm in first pharma bet
Somerset Indus Capital Partners has picked up a minority stake in Gujarat-based Globela Pharma Pvt Ltd, marking the healthcare-focused...
Healthcare
Asian Institute of Gastroenterology ropes in Goldman Sachs to craft Quadria exit
Asian Institute of Gastroenterology (AIG) has hired investment bank Goldman Sachs to facilitate a full exit for its private equity...
Healthcare
Quadria Capital-backed Concord Biotech Pvt pivots to IPO, appoints banker
Quadria Capital-backed Concord Biotech has appointed a merchant bank as it moves a step forward towards raising capital via a...
Healthcare
Rainbow Hospitals hires bankers for $300mn IPO
Rainbow Children’s Medicare Pvt. Ltd, which operates a chain of pediatric hospitals under the brand Rainbow Hospitals, has...
Healthcare
Apax stares at windfall from investment in IPO-bound Healthium Medtech
London-based private equity firm Apax Partners may triple its less than three-year-old investment in surgical, post-surgical and...
Healthcare
Temasek-backed Dr Agarwal's eyes $150 mn in new funding; ADV Partners to exit
Dr Agarwal’s Health Care Ltd has hired bankers to raise at least $150 million (Rs 1091 crore), just over two ......
Healthcare
Quadria makes first exit from India portfolio as Reliance buys Strand
Healthcare focused private equity firm Quadria Capital has struck its first exit from India portfolio facilitated by the acquisition...
Healthcare
Siguler Guff invests in InvAscent backed medical devices maker Relisys
US multi-strategy private equity firm Siguler Guff & Company has invested Rs 100 crore in medical devices maker Relisys Medical...
Healthcare
Everstone Capital preparing to exit Sahyadri Hospitals
Everstone has initiated the process to exit Sahyadri Hospitals, in which the private equity firm had invested just a little ......
Healthcare
Kedaara gets over 5X returns from Vijaya Diagnostic
Homegrown private equity firm Kedaara is sitting on attractive annualized returns of 44% from its investment in IPO-bound Vijaya...









